CCRB Logo

Trial History Detail on 2005-09-08

CUHK_CCT00042

2005-09-08

Retrospective

RGC grant and Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong

Nil

Nil

CHAN Wai Man

27623168

telephone

CHAN Wai Man

27623168

telephone

A Randomized, Controlled Trial of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization in Pathologic Myopia in Chinese

Yes

2002-04-01

Eye Diseases

Procedure

Photodynamic therapy

24 months

observation

Inclusion criteria: aged 18 years or older CNV either in the subfoveal or juxtafoveal area Area of CNV „d 50% of the area of the total lesion Greatest linear dimension of the entire lesion must not exceed 5400 £gm Best-corrected visual acuity score of at least 34 letters (Snellen equivalent, approximately 20/200 or better) Understand the study and sign the informed consent Exclusion criteria: Other clinical features suggesting that the CNV may be secondary to the other causes other than pathologic myopia (such as large drusen, geographical atrophy, choroioretinal scar) Tear (rip) of the retinal pigment epithelium Any other significant concurrent ocular diseases in study eye disease that has compromised or could compromise vision in the study eye History of the other prior forms of treatment including photodynamic therapy, laser, surgery Active hepatitis or clinically significant liver disease Porphyria or hypersensitivity/allergy to treatment (fluorescein, verteporfin) Pregnancy

Randomized

Placebo

Single-blind

Single group

2003-01-01

72

Recruiting

Visual acuity

changes in cnv by angiography and optical coherent tomography

No

2013-01-14


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.